Dr. Shane Pearce

Dr. Shane Pearce
Fellowship-trained urologic oncologist Shane Pearce, MD, provides high-quality urological care for all types of benign and malignant urological conditions. Dr. Pearce is known for offering compassionate and attentive care to the men and women at Spokane Urology in Spokane, Washington. Dr. Pearce is a native of western Montana and is excited to be back in the Inland Northwest with his family. Dr. Pearce graduated with honors from the University of Wisconsin-Madison in Madison, Wisconsin. He completed a six-year urology residency at the University of Chicago Medical Center in Chicago, Illinois, — the highest volume, minimally invasive robotic surgery program in Illinois. Dr. Pearce completed a two-year Society of Urologic Oncology-accredited fellowship at the University of Southern California in Los Angeles. Dr. Pearce has performed hundreds of complex endoscopic, open and robotic surgeries for the full spectrum of benign and malignant urologic disorders. His focus is on care for patients with BPH, kidney stones, and all urologic malignancies. Always learning and furthering his skills, Dr. Pearce is involved in numerous research and teaching pursuits. He performs basic science research and population-based health outcomes research to better understand and treat patients. Dr. Pearce has published over 40 peer-reviewed textbook chapters and journal articles. He serves as peer-reviewer for several major urologic journals and was awarded the Resident and Medical Student Teaching Award during his fellowship. Dr. Pearce also teaches as a clinical assistant professor at Washington State University College of Medicine in Spokane.
Medical School:

University of Wisconsin School of Medicine and Public Health


University of Chicago


University of Southern California

All surgical treatments have inherent and associated side effects. Individual’s outcomes may depend on a number of factors, including but not limited to patient characteristics, disease characteristics and/or surgeon experience. The most common side effects are mild and transient and may include mild pain or difficulty when urinating, discomfort in the pelvis, blood in the urine, inability to empty the bladder or a frequent and/or urgent need to urinate, and bladder or urinary tract infection. Other risks include ejaculatory dysfunction and a low risk of injury to the urethra or rectum where the devices gain access to the body for treatment. Further, there may be other risks as in other urological surgery, such as anesthesia risk or the risk of infection, including the potential transmission of blood borne pathogens. For more information about potential side effects and risks associated with Aquablation therapy for Benign Prostatic Hyperplasia (BPH) treatment, speak with your urologist or surgeon. Prior to using our products, please review the Instructions for Use, Operator’s Manual or User Manual, as applicable, and any accompanying documentation for a complete listing of indications, contraindications, warnings, precautions and potential adverse events. No claim is made that the AquaBeam Robotic System will cure any medical condition, or entirely eliminate the diseased entity. Repeated treatment or alternative therapies may sometimes be required.

Rx Only